Back

GLP-1 receptor agonists in cardiorenal disease

31 August 2025 (18:00 - 18:15)
Organised by: Logo
Congress Presentation Part of: Beyond weight loss: cardiometabolic benefits of GLP-1 receptor agonists Metabolism ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Professor Nikolaos Fragakis

Hippokration General Hospital of Thessaloniki, Thessaloniki (Greece)

3 More presentations in this session

Presentation thumbnail
How has the concept of incretin mimetics evolved since SELECT?
Professor N. Sattar (Glasgow, GB)
Slides Video
Presentation thumbnail
Vascular effects of GLP-1 and other incretin mimetics
Professor E. Osto (Graz, AT)
Slides Video
Presentation thumbnail
Beyond weight loss: cardiometabolic benefits of GLP-1 receptor agonists - discussion

Access the full session

Session thumbnail
Beyond weight loss: cardiometabolic benefits of GLP-1 receptor agonists
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 18:00 CET
You may be interested in
thumbnail
Congress Session
Beyond weight loss: cardiometabolic benefits of GLP-1 receptor agonists
thumbnail
Congress Presentation
Heart failure and renal outcomes in patient treated with GLP1 agonists.
thumbnail
Congress Presentation
Beyond blood glucose: the cardiovascular and renal effects of incretin therapies and SGLT2 inhibitors

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources